Navigation Links
Vermillion Presents Critical Data From Its OVA1 Clinical Trial
Date:2/10/2009

Study Presented at Society of Gynecologic Oncologists' 40th Annual Meeting - on Women's Cancer

FREMONT, Calif., Feb. 10 /PRNewswire-FirstCall/ -- Vermillion, Inc. (OTC Bulletin Board: VRML), a molecular diagnostics company, presented data from its prospective OVA1 clinical trial at the Society of Gynecologic Oncologists' (SGO) 40th Annual Meeting on Women's Cancer in San Antonio, TX (Poster 196). The study entitled "A biomarker panel for distinguishing between malignant and benign ovarian tumors" was co-authored by Fred Ueland, MD, Associate Professor of Gynecologic Oncology at the University of Kentucky and Principal Investigator of the OVA1 clinical trial, and Zhen Zhang, PhD, Associate Professor of Pathology at the Johns Hopkins University School of Medicine as well as Vermillion scientists.

Details of the poster are available in the attached link "A biomarker panel for distinguishing between malignant and benign ovarian tumors." The primary aim of the study was to determine the ability of our proprietary OvaCalc algorithm to estimate the risk of malignancy in pre and postmenopausal women who are scheduled for surgery with an ovarian mass. The data demonstrates that the OvaCalc algorithm can effectively identify women with a higher likelihood of malignancy. Within the study population, the OvaCalc algorithm also detected 90% of Stage I epithelial ovarian cancer cases and 100% of stage 2-4 cancers while maintaining a greater than 90% negative predictive value among both premenopausal and postmenopausal patients.

"We are extremely pleased with the significant results of the OVA1 prospective clinical trial. A major strength of the OVA1 prospective clinical trial was its inclusion of patients seen at a variety of clinical settings where the inten
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2009 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Vermillion Renews Strategic Alliance Agreement With Quest Diagnostics, Inc.
2. Vermillion Files 510(k) Application With U.S. Food & Drug Administration for OVA1 Ovarian Tumor Triage Test
3. Vermillion and the Ohio State University Report That Novel Diagnostic Test May Help Predict Risk for Relapse of TTP, A Serious Blood Disorder
4. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
5. Vermillion Receives Award From the Society of Gynecologic Oncologists
6. Sequoia Pharmaceuticals Presents Proof of Clinical Concept of SPI-452, a Novel Pharmacokinetic Enhancer
7. EntreMed Presents Initial Clinical Results for ENMD-2076
8. Access Pharmaceuticals Presents new Combination Data on the Companys Angiolix(R) Therapeutic Monoclonal Antibody
9. Genaera Presents Promising Preclinical Data for Trodusquemine (MSI-1436) at Keystone Symposia
10. Agendia Supports High Profile CME Symposium and Presents Compelling Data at the 2008 San Antonio Breast Cancer Symposium
11. Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... , May 20, 2013  B. Braun Medical ... and environmental safety with products, services and education ... feature its innovative Outlook® 400ES and Space Infusion ... capabilities at the American Association of Critical-Care Nurses ... Boston Convention Center. ...
(Date:5/20/2013)... 2013  Uroplasty, Inc. (Nasdaq: UPI ) ... the fiscal fourth quarter and full year ended March ... 30, 2013. The Company will host a conference call ... 30, 2013 at 4:30 p.m. Eastern Time (3:30 p.m. ... call should dial 888-549-7750, no passcode is necessary. To ...
(Date:5/20/2013)... , May 20, 2013 /PRNewswire-iReach/ -- It is no secret ... third being overweight or obese gyms and supplement companies are ... the condition is primarily related to dietary issues and a ... the result of a glandular problem or even a vitamin ... common vitamin deficiency is a lack of vitamin b12 ...
Breaking Medicine Technology:B. Braun Committed To Improving Patient Safety 2Uroplasty To Announce Fiscal Fourth Quarter And Full Year 2013 Financial Results On May 30, 2013 2USB12Shots.com Discusses the Possibility of B12 Shots for Weight Loss 2
... LOUIS, Oct. 12 Orion Genomics today announced that ... agreement with the molecular diagnostics unit of Novartis Pharma ... novel epigenetic biomarkers, and both parties have rights to ... fields. Under the terms of the agreement, Orion ...
... VIENNA, Austria, October 12 ... enzymes for the,chemical industry, announced today that it ... position of Senior Vice President Marketing &,Sales. Dr. ... of EUCODIS,Bioscience, products. In 2009 the Company has ...
Cached Medicine Technology:Orion Genomics Enters Discovery Collaboration and License Agreement to Advance Personalized Diagnostics 2EUCODIS Bioscience Appoints Bhupinder Hundle to Senior Vice President Marketing & Sales 2EUCODIS Bioscience Appoints Bhupinder Hundle to Senior Vice President Marketing & Sales 3
(Date:5/21/2013)... (PRWEB) May 21, 2013 The ... to announce four transitions for its Board of Directors. ... the Western Michigan University School of Medicine, has been ... Medical Education at the University of California San Diego, ... Executive Officer of the Nebraska Medical Center, is the ...
(Date:5/21/2013)... Lapeer, MI (PRWEB) May 21, 2013 ... Support Group meeting in Lapeer on , June 11th. ... – 8:30pm, Location: Lapeer Regional Medical Center,     Conference Room ... 48446 , These meetings are designed to assist people ... connected with one another, and to get a better ...
(Date:5/21/2013)... The birth control safety advocates at DrugRisk.com ... the contraceptive NuvaRing. A new report shows the number ... increased in recent months*. , DrugRisk was created to ... the latest safety alerts, recalls, studies and legal news. ... side effects and decide if they need legal advice. ...
(Date:5/20/2013)... 21, 2013 USA Book News announced ... to Peak Performance" won the top honor in its ... Chosen over a multitude of international titles published from ... critical acclaim from both mainstream and new age audiences ... physically and spiritually. , “The Infinity Zone” ...
(Date:5/20/2013)... The automated external defibrillator market ... categories - semi-automated and fully automated defibrillators. Based ... categories, namely, hospitals, pre-hospital, public access, alternate care, ... Automated external defibrillators play an important role in ... Considering the life-saving potential of AEDs, legislations requiring ...
Breaking Medicine News(10 mins):Health News:New Board of Directors Leadership for The Match- National Resident Matching Program® 2Health News:New Board of Directors Leadership for The Match- National Resident Matching Program® 3Health News:DrugRisk Update Shows Increase in NuvaRing Blood Clot Lawsuits 2Health News:Mystic Ink Publishing's "The Infinity Zone" Wins Top Honor - International Book Awards 2Health News:Mystic Ink Publishing's "The Infinity Zone" Wins Top Honor - International Book Awards 3Health News:North America Leads Automated External Defibrillator Market (AED), Says New Research Report at ReportsnReports.com 2Health News:North America Leads Automated External Defibrillator Market (AED), Says New Research Report at ReportsnReports.com 3
... incidence of ,food insecurity, , , TUESDAY, Nov. 4 (HealthDay News) ... to be underfed and undernourished, a new study finds. , ... but children feel the impact the most, said study author ... School of Medicine. , "We know that there are long-term ...
... Vericept, the leading provider,of data loss prevention ... announce the achievement of a significant milestone ... healthcare industry have selected,Vericept,s DLP solution to ... well as safeguard patient data and other ...
... 4 Jennerex, Inc. (San Francisco, CA,and Ottawa, Canada) ... M.D., President and Chief Executive Officer,will present an overview ... Renshaw,Healthcare Conference in New York on November 11, 2008 ... the Palace Hotel, New York., A webcast of ...
... adds 400,000 members and brings Blue branded dental ... Pa., Nov. 4 Capital BlueCross announced,today that ... held,corporation headquartered in Alexandria, VA. The move by ... throughout the,Commonwealth of Pennsylvania and the Mid-Atlantic Region., ...
... sonography or ultrasound to visualise organs and other internal ... has developed a computer model that can predict the ... computer model is capable of processing large quantities of ... and a parallel supercomputer. Erasmus University Medical Centre and ...
... of,Hematology (ASH), the world,s largest professional society of ... Committee, the,governing body of the organization. The officers ... J. Evan Sadler, MD, PhD, will serve a ... as president-elect and president. Charles,Abrams, MD, will serve ...
Cached Medicine News:Health News:Smokers' Homes More Likely to House Hungry Kids 2Health News:Smokers' Homes More Likely to House Hungry Kids 3Health News:Vericept Announces 100 Customers in Healthcare Industry for Sensitive Data Protection 2Health News:Jennerex To Present at Rodman & Renshaw 10th Annual Healthcare Conference 2Health News:Capital BlueCross Acquires Dominion Dental 2Health News:New Leadership Elected to the American Society of Hematology 2
Micro instruments designed to provide maximum grasping, resecting capability, and excellent maneuverability for easy access to tight, small joints (wrist, elbow, and ankle).,Features pinless hinge d...
Made exclusively from LactoSorb Resorbable Copolymer....
... The Biosteon™ screw is made of ... Acid (PLLA). It not only has the ... it has the osteoconductive potential of bone. ... BTB and Soft Tissue procedures. Biosteon™ increases ...
The Stryker Graft Workstation offers the surgeon flexibility in graft preparation. The posts are interchangeable and the system adapts to both soft tissue and bone grafts selection. Sizing gauges off...
Medicine Products: